AI-generated summary
The authors randomized 60 adults with chronic neck myofascial pain syndrome to active 904 nm gallium-arsenide laser or placebo laser for two weeks. The active group showed improvements in all measures, while the placebo group improved only in resting pain score. The authors conclude the short laser course was effective for pain relief, function and quality of life.
- Participants
- 60
- Who or what was studied
- Adults with chronic myofascial pain syndrome in the neck
- Wavelengths
- 904 nm
- Limits stated in the abstract
- The abstract does not describe the certainty of the evidence or the length of effects beyond the 12-week follow-up point.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 904 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Depression. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.